Inhibitor Shows Potential To Protect Infant Brain

St. Louis, April 27, 1998 -- Several biotech companies are exploring the idea that compounds called caspase inhibitors might minimize the brain damage that results from blood and oxygen shortage. Now researchers at Washington University School of Medicine in St. Louis have shown that one such compound protects newborn rats from damage.

"To our knowledge, this is the first demonstration that delayed treatment with a caspase inhibitor, even when given systemically, can be neuroprotective in an injury model," says David M. Holtzman, M.D., chief author and assistant professor of neurology and molecular biology & pharmacology. "If these compounds prove not to be toxic and are able to come into clinical use, it appears there may be a window of at least several hours when one could administer them."

The findings are published in the May 1 issue of Journal of Clinical Investigation. Former postdoctoral fellow Yu Cheng, M.D., Ph.D., is first author.

An interruption in the supply of blood and oxygen to the brain in the womb or during or after birth is the largest contributor to brain degeneration in children. Life-time consequences include mental retardation, seizures and cerebral palsy, which affects 500,000 Americans.

Holtzman mimics the condition by interrupting the blood supply to one side of a newborn rat's brain and briefly lowering the oxygen content of the air. This procedure kills neurons, which results in loss of brain tissue. Holtzman and colleagues showed, however, that while some neurons swell up and burst, as happens rapidly in adults with head injury or stroke, many neurons slowly shrink through a process resembling cell suicide.

A series of genetically programmed steps lead to cell suicide or apoptosis. The rat brain cells appeared to die this way because their demise was delayed, beginning six hours after the procedure and peaking between 18 and 24 hours. Just before they died, the cells activated their casp

Contact: Linda Sage
Washington University School of Medicine

Page: 1 2 3

Related biology news :

1. Inhibitor of novel cancer target, LPAAT-beta, demonstrates selective anti-cancer effects
2. Natures own medicine for vision loss: Inhibitor of angiogenesis found by biologists at The Scripps Research Institute
3. Research Findings Suggest Potent, Broad-Spectrum Antiviral Activity For Vertexs Investigational IMPDH Inhibitor VX-497
4. Use Of Protease Inhibitors For HIV Associated With Dramatic Rise In Oral Warts
5. How Super Are The "Super Aspirins"? -- New COX-2 Inhibitors May Elevate Cardiovascular Risk
6. Cholesterol Inhibitors In Garlic Identified
7. Phase III Results Suggest Potent Antiviral Activity For Vertex And Glaxo Wellcomes Second-Generation HIV Protease Inhibitor Agenerase TM
8. New Class Of Protease Inhibitors May Be Effective In Treating One Of Latin Americas Most Devastating Diseases
9. HIV-Positive Injection Drug Users Often Dont Receive Protease Inhibitors And May Not Be Aware Of The Drug
10. New Hampshire Study Shows Well Water Has Higher Arsenic Levels Than Municipal Water
11. New Protein-Like Polymer Shows Promise For Blood Vessel Replacement

Post Your Comments:

(Date:12/5/2018)... ... 04, 2018 , ... Urological Associates of Southern Arizona today ... Excellence. The designation recognizes that Dr. Choi has achieved a high level of ... care for men suffering from symptoms associated with Benign Prostatic Hyperplasia or BPH. ...
(Date:11/29/2018)... (PRWEB) , ... November 29, 2018 , ... ... in Semba Biosciences with the intention of acquiring full ownership. The transaction was ... Agreement was executed on November 14, 2018. “We are extremely pleased to team ...
(Date:11/27/2018)... ... November 27, 2018 , ... LabArchives ... worked together to integrate the LabArchives Classroom Edition with Current Protocols Essential Laboratory ... be available beginning January of 2019. , The integration of LabArchives ...
Breaking Biology News(10 mins):
(Date:11/27/2018)... ... November 27, 2018 , ... New patients in need of a dental ... treatment, with or without a referral. Dr. Myers has many years of experience improving ... implants, bridges and custom crowns. , As a dedicated cosmetic dentist , ...
(Date:11/20/2018)... ... November 19, 2018 , ... The International Society for ... Chinese translation of Best Practices: Recommendations for Repositories, Fourth Edition. , The Fourth ... advancing the science of biobanking to meet the needs of a growing industry. ...
(Date:11/20/2018)... ... , ... Each year Forbes receives thousands of nominations for candidates wishing to ... individuals under 30 years of age. The Forbes 30 Under 30 list showcases the ... Venture Capital and Science. , In 2017, Visikol CEO Dr. Michael Johnson was ...
(Date:11/15/2018)... SAN FRANCISCO (PRWEB) , ... November 14, 2018 ... ... Indiegogo campaign, bringing the world’s first self-learning snore-reduction mask to the public. It ... to a poorer quality of sleep for themselves and their partner. The resulting ...
Breaking Biology Technology:
Cached News: